We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
(+4.6%)
Cap. Flow
-$221M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$114M |
| 2 |
AET
Aetna Inc
AET
|
+$96.3M |
| 3 |
Travelers Companies
TRV
|
+$94.5M |
| 4 |
CHK
Chesapeake Energy Corporation
CHK
|
+$89M |
| 5 |
Ameren
AEE
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$247M |
| 2 |
Verizon
VZ
|
+$186M |
| 3 |
Medtronic
MDT
|
+$150M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$126M |
| 5 |
Johnson Controls International
JCI
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.44% |
| 2 | Technology | 14.68% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 11.1% |
| 5 | Energy | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECOM
601
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $3.9M | 0.02% |
148,000
+48,000
| +48% | +$1.22M |
|
|
WPS
602
DELISTED
iShares International Developed Property ETF
WPS
| $3.89M | 0.02% |
99,740
-3,480
| -3% | -$132K |
|
|
RGC
603
DELISTED
Regal Entertainment Group
RGC
| $3.88M | 0.02% |
183,880
-439,110
| -70% | -$8.59M |
|
|
CEMP
604
DELISTED
Cempra, Inc.
CEMP
| $3.87M | 0.02% |
360,863
+33,311
| +10% | +$322K |
|
|
MLNX
605
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.87M | 0.02% |
111,000
| – | – |
|
606
Snap-on
SNA
$19.4B
| $3.86M | 0.02% |
32,600
| – | – |
|
607
Flotek Industries
FTK
$977M
| $3.86M | 0.02% |
20,000
+833
| +4% | +$146K |
|
|
VIRX
608
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.85M | 0.02% |
2,815
-113
| -4% | -$131K |
|
|
EOPN
609
DELISTED
E2OPEN INC COM STK (DE)
EOPN
| $3.85M | 0.02% |
186,000
+28,000
| +18% | +$510K |
|
610
United Therapeutics
UTHR
$21.5B
| $3.8M | 0.02% |
42,900
+17,730
| +70% | +$1.71M |
|
611
Newmont
NEM
$131B
| $3.76M | 0.02% |
147,920
-203
| -0.1% | -$4.89K |
|
|
SN
612
DELISTED
Sanchez Energy Corporation
SN
| $3.76M | 0.02% |
100,000
+35,000
| +54% | +$1.1M |
|
613
Church & Dwight Co
CHD
$22.4B
| $3.75M | 0.02% |
107,264
-3,626
| -3% | -$125K |
|
614
Teradyne
TER
$52B
| $3.72M | 0.02% |
190,000
| – | – |
|
|
MHFI
615
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $3.7M | 0.02% |
44,570
+18,470
| +71% | +$1.46M |
|
616
Range Resources
RRC
$9.79B
| $3.68M | 0.02% |
42,279
-219
| -0.5% | -$19.6K |
|
|
LLL
617
DELISTED
L3 Technologies, Inc.
LLL
| $3.65M | 0.02% |
30,200
| – | – |
|
618
CBRE Group
CBRE
$40.6B
| $3.65M | 0.02% |
113,807
-2,306
| -2% | -$66.6K |
|
|
ARIA
619
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.62M | 0.02% |
568,527
-11,517
| -2% | -$79.2K |
|
620
iShares Global Infrastructure ETF
IGF
$10.2B
| $3.62M | 0.02% |
81,610
+7,930
| +11% | +$339K |
|
621
Manitowoc
MTW
$741M
| $3.62M | 0.02% |
121,436
-19,209
| -14% | -$510K |
|
|
AMBR
622
DELISTED
Amber Road Inc
AMBR
| $3.55M | 0.01% |
+220,000
| New | +$3.15M |
|
623
Reinsurance Group of America
RGA
$16.2B
| $3.54M | 0.01% |
44,916
+22,057
| +96% | +$1.72M |
|
|
HOS
624
Hornbeck Offshore Services, Inc.
HOS
$2.89B
| $3.53M | 0.01% |
134,300
+74,100
| +123% | +$1.76M |
|
625
Oceaneering
OII
$4.75B
| $3.52M | 0.01% |
45,000
-7,000
| -13% | -$514K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2014 Portfolio in Review
As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
- Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
- Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
- Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
- Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
- Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
- Axa opened 103 new positions and closed 115 in Q2 2014.
- Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.
Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.